Documentdetail
ID kaart

oai:pubmedcentral.nih.gov:1136...

Onderwerp
Case Report
Auteur
Lange, Silvan Oppel, Eva Winkler, Marius Ruëff, Franziska
Langue
en
Editor

Dustri-Verlag Dr. Karl Feistle

Categorie

Allergologie Select

Jaar

2024

vermelding datum

04-09-2024

Trefwoorden
insect venom elevated patients
Metriek

Beschrijving

Mastocytosis or an elevated basal serum tryptase (bST) level are known risk factors for patients with insect venom allergy.

We report on 3 patients with a history of severe anaphylactic insect sting reactions who underwent a detailed workup for insect venom allergy before starting venom immunotherapy.

In addition to insect venom sensitization, an elevated concentration of bST (15.5, 20.8, and 23.2 µg/L) was found in all cases.

There was no evidence of mastocytosis in the skin (MIS).

Further testing revealed hereditary α-hypertryptasemia (HαT) in 2 patients and a D816V mutation by liquid biopsy in 1 patient, which is a minor diagnostic criterion for indolent systemic mastocytosis.

Even without iliac crest puncture, causes of elevated bST can be narrowed down with minimally invasive diagnostic measures.

As this has practical implications, patients with elevated bST should always undergo further work-up to determine the cause of this abnormal finding.

Lange, Silvan,Oppel, Eva,Winkler, Marius,Ruëff, Franziska, 2024, Diagnostic measures in patients with severe insect sting reactions and elevated baseline serum tryptase levels, Dustri-Verlag Dr. Karl Feistle

Delen

Bron

Artikelen aanbevolen door ES/IODE AI

Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial
gravis myasthenia study clinical phase baseline improvement mg-adl 340 week trial placebo period mg maintenance qw